Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

por Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.
Publicado 2022

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmona...

por Minhas, Jasleen, Narasimmal, Sai Prasanna, M. Bull, Todd, Marco, Teresa De, McConnell, John Wesley, Lammi, Matthew R., Thenappan, Thenappan, P. Feldman, Jeremy, S. Sager, Jeffrey, B. Badesch, David, Ryan, John J., C. Grinnan, Daniel, Zwicke, Dianne, M. Horn, Evelyn, Elwing, Jean M., Moss, John E., Eggert, Michael, Shlobin, Oksana A., P. Frantz, Robert, D. Bartolome, Sonja, Mathai, Stephen C., Mazimba, Sula, C. Pugliese, Steven, Al-Naamani, Nadine
Publicado 2021